Jill Frew leads Cain Brothers’ healthcare technology practice, and works with a variety of HCIT businesses targeting the payer, provider, consumer and pharma markets. Ms. Frew joined Cain Brothers in 2006 and has over 25 years of experience advising both public and private companies in a variety of M&A, capital raising, and strategic advisory transactions. Ms. Frew has executed transactions across several healthcare verticals, including managed care, provider and pharma services, fintech and HCIT. During her career Ms. Frew has represented or sold companies to American Well, Peloton, Masimo, Guidewell, Avizia, CVS, RedCard Systems, Cytel, Cognizant, WNS, Baxter, Premier Healthcare Exchange (nka Zelis Healthcare), Reed Group, Omnicom Group, Guardian Life Insurance, Cardinal Health, UnitedHealth, Bracket Global and Stanley Black & Decker. In addition, Ms. Frew has recently led successful recapitalizations with many leading financial sponsors.
Ms. Frew began her investment banking career at Wachovia Corporation as an Analyst in the M&A Group. She then went on to work in the investment banking group of Wheat First Securities, where she focused on M&A advisory work and public offerings for clients, primarily in the healthcare industry. Ms. Frew then spent three years as head of the Corporate Development group of PhyAmerica, where she led the M&A activity for this $1 billion healthcare services conglomerate that consummated approximately 100 acquisitions during Ms. Frew’s tenure. In 1995, Ms. Frew co-founded Townsend Frew & Co., a healthcare-focused M&A boutique that was later acquired by Edgeview Partners. Ms. Frew earned a BS in Finance from Utah State University and an MBA from The College of William & Mary.